CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

All articles

Filters:
Show search box
2015-10-19
Vaccine against AIDS in Phase I clinical trials

Vaccine against AIDS in Phase I clinical trials

A vaccine based on HIV gp120 protein is a unique product for 15 years protection against infection. Unique, because it has been introduced by the team of Prof. Robert Gallo – a pioneer in the field of AIDS research and previous critic of disease-related vaccination.... Read more
Tags clinical trials , HIV , vaccine , AIDS , gp120
2015-08-11
Finally! We have a vaccine against malaria! Unless we don’t…

Finally! We have a vaccine against malaria! Unless we don’t…

A vaccine called Mosquirix or RTS,S has been ready to use for the past couple of years. What prevents European Medicines Agency and World Health Organization from its official approval is the low efficacy.... Read more
Tags EMA , malaria , africa , WHO , vaccine , Mosquirix , RTS , S
2015-08-05
European H1N1 influenza vaccine may trigger narcolepsy

European H1N1 influenza vaccine may trigger narcolepsy

Flu pandemic in 2009 and related vaccination have left an undesirable stigma throughout Europe. More than 1300 people who received a vaccine called Pandemrix has developed narcolepsy. ... Read more
Tags flu , influenza , vaccination , vaccine , Pandemrix , narcolepsy , H1N1 , pandemic
2015-02-11
Tau-based vaccines as a novel tool for Alzheimer’s Disease treatment

Tau-based vaccines as a novel tool for Alzheimer’s Disease treatment

Alzheimer’s disease is the most frequent cause of dementia. Currently, there are various studies all over the world trying to elaborate efficient therapies to help patients. Among them, there are approaches associated with immunomodulation, thus application of vaccines. One of the newest idea is to t... Read more
Tags Alzheimer's disease , treatment , tau , amyloid , vaccine , ACL-35